All payments made in the preview are in test mode. Read more
Sign in
Back to Atlas
APotentially durableResearch-only / high verification need
CMP-0085
Veterinary/discontinued/restricted

Mibolerone / Cheque Drops

Ergogenic / AAS

Extremely potent androgenic/anabolic veterinary steroid

Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type
17α-alkylated AAS
Primary mechanism
Androgen receptor agonist; A:A ratio often reported ~4100:1800
Primary market use
Veterinary estrus suppression; performance misuse history

Pharmacology

Molecular weight (Da)
302.45
Oral bioavailability
Oral; highly potent 17α-alkylated steroid
Half-life
~4 h (approx.)
Route tags
Route-dependent / verify
Evidence level
Veterinary/historical
Clinical status
Veterinary/discontinued/restricted
Value-for-money score
1 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Very high potency but poor value due to narrow margin and limited legitimate use; ratio values are preclinical index values.

Educational and organizational assistant matrix. Not medical advice.

BioChrysalis Atlas is an educational, organizational, and tracking asset. It does not provide medical advice, diagnosis, treatment, prescriptions, or individualized dosing instructions. Compound profiles, protocol notes, and dosage fields summarize publicly discussed or source-listed reference patterns and are not recommendations. Consult a qualified healthcare professional before starting, stopping, or modifying any compound, medication, or supplement protocol.

© BioChrysalis · Evolve · Ascend · Transcend